JP2008543729A5 - - Google Patents

Download PDF

Info

Publication number
JP2008543729A5
JP2008543729A5 JP2007558257A JP2007558257A JP2008543729A5 JP 2008543729 A5 JP2008543729 A5 JP 2008543729A5 JP 2007558257 A JP2007558257 A JP 2007558257A JP 2007558257 A JP2007558257 A JP 2007558257A JP 2008543729 A5 JP2008543729 A5 JP 2008543729A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007558257A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008543729A (ja
JP5110697B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2007558257A priority Critical patent/JP5110697B2/ja
Priority claimed from JP2007558257A external-priority patent/JP5110697B2/ja
Publication of JP2008543729A publication Critical patent/JP2008543729A/ja
Publication of JP2008543729A5 publication Critical patent/JP2008543729A5/ja
Application granted granted Critical
Publication of JP5110697B2 publication Critical patent/JP5110697B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2007558257A 2005-06-27 2006-06-26 固形製剤 Active JP5110697B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007558257A JP5110697B2 (ja) 2005-06-27 2006-06-26 固形製剤

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005187214 2005-06-27
JP2005187214 2005-06-27
JP2007558257A JP5110697B2 (ja) 2005-06-27 2006-06-26 固形製剤
PCT/JP2006/313176 WO2007001067A2 (en) 2005-06-27 2006-06-26 Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012177601A Division JP5456857B2 (ja) 2005-06-27 2012-08-09 固形製剤

Publications (3)

Publication Number Publication Date
JP2008543729A JP2008543729A (ja) 2008-12-04
JP2008543729A5 true JP2008543729A5 (cg-RX-API-DMAC7.html) 2009-08-06
JP5110697B2 JP5110697B2 (ja) 2012-12-26

Family

ID=37460221

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007558257A Active JP5110697B2 (ja) 2005-06-27 2006-06-26 固形製剤
JP2012177601A Active JP5456857B2 (ja) 2005-06-27 2012-08-09 固形製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012177601A Active JP5456857B2 (ja) 2005-06-27 2012-08-09 固形製剤

Country Status (3)

Country Link
JP (2) JP5110697B2 (cg-RX-API-DMAC7.html)
TW (1) TWI388345B (cg-RX-API-DMAC7.html)
WO (1) WO2007001067A2 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5940073A (en) 1996-05-03 1999-08-17 Starsight Telecast Inc. Method and system for displaying other information in a TV program guide
GT200600371A (es) * 2005-08-17 2007-03-21 Formas de dosis sólidas de valsartan y amlodipina y método para hacer las mismas
US9113107B2 (en) 2005-11-08 2015-08-18 Rovi Guides, Inc. Interactive advertising and program promotion in an interactive television system
KR101628028B1 (ko) * 2006-06-27 2016-06-08 다이이찌 산쿄 가부시키가이샤 압축 제제
US20080175872A1 (en) * 2006-09-28 2008-07-24 Osmotica Corp. Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid
US8832742B2 (en) 2006-10-06 2014-09-09 United Video Properties, Inc. Systems and methods for acquiring, categorizing and delivering media in interactive media guidance applications
KR101247583B1 (ko) * 2006-12-08 2013-03-26 한미사이언스 주식회사 암로디핀 또는 이의 약제학적 허용가능한 염, 및 로자탄또는 이의 약제학적 허용가능한 염을 함유하는 약제학적조성물
TWI414310B (zh) * 2006-12-26 2013-11-11 Daiichi Sankyo Co Ltd 溶出性改善之醫藥品組成物
TWI488658B (zh) * 2006-12-26 2015-06-21 Daiichi Sankyo Co Ltd 溶出性之改善方法
TWI402083B (zh) * 2006-12-26 2013-07-21 Daiichi Sankyo Co Ltd 固形製劑及其安定化方法
CN101969933B (zh) * 2008-01-25 2016-03-30 杜奥-戈公司 通过包覆物结合的口服药物的组合
EP2253318B1 (en) 2008-03-13 2014-08-06 Daiichi Sankyo Company, Limited Improvement of dissolvability of preparation containing olmesartan medoxomil
TW201014850A (en) * 2008-09-25 2010-04-16 Takeda Pharmaceutical Solid pharmaceutical composition
US9161933B2 (en) * 2009-01-23 2015-10-20 Hanmi Science Co., Ltd Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same
WO2011001202A1 (en) * 2009-06-30 2011-01-06 Sanofi-Aventis Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
JP5886530B2 (ja) * 2010-02-26 2016-03-16 第一三共株式会社 錠剤
JP5421945B2 (ja) * 2010-03-10 2014-02-19 大日本住友製薬株式会社 イルベサルタンとアムロジピンまたはその塩を含有する医薬組成物
JP5824222B2 (ja) * 2010-03-31 2015-11-25 第一三共株式会社 固形製剤の製造方法
EP2632438A1 (en) 2010-10-27 2013-09-04 KRKA, tovarna zdravil, d.d., Novo mesto Multilayer pharmaceutical composition comprising telmisartan and amlodipine
UY33772A (es) * 2010-12-09 2012-07-31 Lg Life Sciences Ltd Composición farmacéutica que comprende clorhidrato de lercanidipina y valsartán como componentes activos y a un método para la preparacion de la misma.
JP6041591B2 (ja) * 2011-09-13 2016-12-14 大日本住友製薬株式会社 イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
WO2014058046A1 (ja) * 2012-10-12 2014-04-17 味の素株式会社 カルシウム拮抗薬/アンジオテンシンii受容体拮抗薬含有医薬製剤
MX2013001277A (es) * 2013-01-31 2014-07-30 Miguel Ángel García Pérez Composicion farmaceutica con un antagonista de los receptores de la angiotensina ii y un bloqueador de los canales de calcio para el tratamiento de la hipertension arterial.
CN103127110A (zh) * 2013-03-18 2013-06-05 吉林省博大伟业制药有限公司 含有血管紧张素ⅱ受体拮抗剂和钙通道阻断剂的复方制剂
CN103271908B (zh) * 2013-05-23 2019-02-12 浙江华海药业股份有限公司 含有替米沙坦和苯磺酸氨氯地平的口服片剂及其制备方法
JP6422868B2 (ja) * 2013-07-23 2018-11-14 第一三共株式会社 高血圧症の予防又は治療のための医薬
CN103908539B (zh) * 2014-05-03 2017-02-01 李全浩 一种治疗高血压的中药组合物及其制备方法及应用
CN104000821B (zh) * 2014-06-02 2020-06-19 浙江华海药业股份有限公司 含有替米沙坦和苯磺酸氨氯地平的口服双层片剂及其制备方法
EP3244880A1 (en) * 2015-01-12 2017-11-22 Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi A stable bilayer pharmaceutical tablet compositions comprising fixed dose of irbesartan and amlodipine
CA3015964C (en) * 2016-03-24 2021-08-03 Daiichi Sankyo Company, Limited Medicine for treating renal disease
CN109432034A (zh) * 2018-12-28 2019-03-08 乐普制药科技有限公司 一种缬沙坦氨氯地平三层片剂及其制备方法
CN110237073B (zh) * 2019-07-10 2022-12-02 安庆回音必制药股份有限公司 一种奥美沙坦酯氨氯地平片及其制备方法
CN114712319B (zh) * 2022-03-25 2024-01-09 北京诺康达医药科技股份有限公司 一种非洛地平盐酸普萘洛尔复方制剂及其制备方法
CN115227662B (zh) * 2022-06-24 2023-11-24 辰欣药业股份有限公司 一种缬沙坦氨氯地平片剂及其制备方法
CN115944600B (zh) * 2022-12-01 2024-05-28 山东齐都药业有限公司 含有替米沙坦和苯磺酸氨氯地平的口服片剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0859470A (ja) * 1994-08-29 1996-03-05 Sankyo Co Ltd シクロペンタ[d]ピリミジン誘導体の溶出性改善製剤
US6395728B2 (en) * 1999-07-08 2002-05-28 Novartis Ag Method of treatment and pharmaceutical composition
DK2260833T3 (da) * 2002-01-16 2013-01-07 Boehringer Ingelheim Pharma Tolags farmaceutisk tablet omfattende telmisartan og et diuretika
JP3751287B2 (ja) * 2002-03-27 2006-03-01 バイエル薬品株式会社 小型化されたニフェジピン有核錠剤
WO2003080057A1 (fr) * 2002-03-27 2003-10-02 Bayer Aktiengesellschaft Comprime-noyau de taille reduite contenant de la nifedipine
EG24716A (en) * 2002-05-17 2010-06-07 Novartis Ag Combination of organic compounds
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations
JP2004300102A (ja) * 2003-03-31 2004-10-28 Kissei Pharmaceut Co Ltd 縮合複素環誘導体、それを含有する医薬組成物およびその医薬用途
US20050209288A1 (en) * 2004-01-12 2005-09-22 Grogan Donna R Compositions comprising (S)-amlodipine malate and an angiotensin receptor blocker and methods of their use
EP1814527B2 (en) * 2004-11-05 2020-11-18 Boehringer Ingelheim International GmbH Bilayer tablet comprising telmisartan and amlodipine

Similar Documents

Publication Publication Date Title
JP2008543290A5 (cg-RX-API-DMAC7.html)
JP2008543728A5 (cg-RX-API-DMAC7.html)
JP2009511485A5 (cg-RX-API-DMAC7.html)
JP2008543729A5 (cg-RX-API-DMAC7.html)
JP2009543688A5 (cg-RX-API-DMAC7.html)
JP2009538387A5 (cg-RX-API-DMAC7.html)
JP2009525726A5 (cg-RX-API-DMAC7.html)
JP2009542573A5 (cg-RX-API-DMAC7.html)
JP2009507826A5 (cg-RX-API-DMAC7.html)
JP2006257115A5 (cg-RX-API-DMAC7.html)
JP2009506999A5 (cg-RX-API-DMAC7.html)
JP2008533230A5 (cg-RX-API-DMAC7.html)
JP2007231207A5 (cg-RX-API-DMAC7.html)
JP2010530463A5 (cg-RX-API-DMAC7.html)
JP2009520703A5 (cg-RX-API-DMAC7.html)
JP2009503140A5 (cg-RX-API-DMAC7.html)
JP2008543830A5 (cg-RX-API-DMAC7.html)
JP2006063441A5 (cg-RX-API-DMAC7.html)
JP2006045672A5 (cg-RX-API-DMAC7.html)
JP2007321035A5 (cg-RX-API-DMAC7.html)
JP2008538930A5 (cg-RX-API-DMAC7.html)
JP2009062402A5 (cg-RX-API-DMAC7.html)
JP2009526126A5 (cg-RX-API-DMAC7.html)
JP2007246653A5 (cg-RX-API-DMAC7.html)
JP2007190226A5 (cg-RX-API-DMAC7.html)